Posted on 06/15/2015 in Blog Post, Press Releases
Former United States Secretary of Commerce Barbara Franklin Joins Pathway Genomics’ Board of Directors
San Diego, CA – June 16, 2015
– Pathway Genomics Corporation
, a global precision medicine company with mobile health solutions for clinical laboratory testing to empower physicians and their patients to take control of their health and wellness, announced today that the 29th
U.S. Secretary of Commerce, The Honorable Barbara Franklin
is joining the company’s Board of Directors.
Click to Tweet
Posted on 06/01/2015 in News, Press Releases
San Diego, CA – June 2, 2015
– Pathway Genomics Corporation, a data-driven global healthcare company and precision medicine clinical laboratory, announced today the launch of BRCATrue™ Hispanic (8-Site)
, a site-specific genetic testing panel consisting of 8 recurrent BRCA1
pathogenic variants found in individuals of Mexican and Hispanic descent.
Posted on 05/19/2015 in News, Press Releases
San Diego, CA – May 19, 2015
- Pathway Genomics Corporation
, a data-driven global healthcare company and precision medicine
clinical laboratory announced today that the sixteenth Chairman of the Joint Chiefs of Staff, retired U.S. Marine General Peter Pace is joining the company’s Board of Directors.
Posted on 05/14/2015 in News, Press Releases
SAN DIEGO, CA / Washington DC
– May 14, 2015
– Pathway Genomics Corporation, a data-driven global healthcare company and global clinical laboratory, today announced that Founder and CEO Jim Plante
has been appointed by the U.S. Secretary of Commerce, Penny Pritzker, and U.S. Trade Representative (USTR), Ambassador Michael Froman to the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health and Science Products (ITAC 3).
Posted on 04/29/2015 in Blog Post, GC
Q: I have a healthy diet, no history of heart disease in my family, and I am overweight but not obese—do I really need to exercise?
SAN DIEGO, Apr 29, 2015 — Mandy Kenyon, MS, RD, CSSD, is Pathway Genomics’ Registered Dietitian and played a major role in developing the customized diet plans that are part of tests such as Pathway Fit. Mandy is available to answer nutrition- and diet-related questions for Pathway’s clients and customers—contact her at email@example.com.
Mandy recently shared a couple of the most common questions she receives in her work as a dietitian, as well as her responses:
Absolutely. Being overweight (a BMI of 25.0–29.9) can have consequences, such as an increased risk of coronary heart disease, high blood pressure, stroke, and type II diabetes. Exercise can reduce these risks, and may improve both your current and future health by lessening the chance of complications later on.
Posted on 04/17/2015 in Blog Post, News
SAN DIEGO, Apr 17, 2015 — Leslie Ordal, M.Sc., a field genetic counselor at Pathway Genomics, answers some frequently asked questions:
Are all genetic changes harmful?
No. In fact, everyone has genetic changes – it’s why we’re all different. Some genetic changes, called pathogenic variants, can be harmful to an individual, and in some cases, to their children if passed down.
Many other genetic changes; however, are quite common and have no known effect on health – we call these benign variants, and they’re just part of natural human variation. Some genetic changes can even be beneficial, such as those associated with reduced risk for certain diseases like Alzheimer disease.
Can I fix a pathogenic variant in my genes?
This is a very common question, and right now the answer is no. Your genes are in almost every cell in your body, and there’s just no way to go in and fix an alteration in the genetic code in each and every cell. However, research is ongoing and may make this a possibility in the future.
Posted on 03/26/2015 in News, Press Releases
SAN DIEGO, Mar 26, 2015
(BUSINESS WIRE) -- Pathway Genomics Corporation, a forward-thinking big data healthcare company and global precision medicine clinical laboratory, announced it has launched ColoTrue™
, a comprehensive panel that combines next-generation sequencing with deletion/duplication analysis to detect pathogenic variants in 15 high-risk colorectal cancer susceptibility genes. Pathway has also launched a smaller panel, LynchSyndromeTrue™, which tests for Lynch syndrome, the most common form of hereditary colon cancer.
Posted on 03/11/2015 in News, Press Releases
San Diego, CA – March 11, 2015
– Pathway Genomics Corporation, a forward-thinking big data healthcare company and global precision medicine clinical laboratory, has announced that endocrinologist Dr. Glenn D. Braunstein is the company’s new Chief Medical Officer. Dr. Braunstein takes on the role after serving on Pathway Genomics’ Strategic Advisory Board. With a special interest in pharmacogenomics, Dr. Braunstein’s first priority will be Pathway Genomics’ pharmacogenomic testing menu.
Posted on 03/10/2015 in Blog Post, Editorial
By Michael Nova, M.D.
Chief Innovation Officer
There has recently (2013-15) been a flurry of human clinical trial publications regarding gene-diet interactions, primarily concerning obesity and related phenotypes.
A new finding by the Genetic Investigation of Anthropometric Traits, or GIANT, consortium has identified 97 gene regions associated with obesity, tripling the number of such genes previously known.
Posted on 02/26/2015 in News, Press Releases
SAN DIEGO, CA
– February 26, 2015
– Pathway Genomics Corporation
, a CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that former Speaker of the U.S. House of Representatives Newt Gingrich has joined its strategic advisory board. A former candidate for president of the United States in 2012, Gingrich has spent more than four decades as a leader in American public life. During his time in Congress, he helped save Medicare from bankruptcy, shepherded FDA reform to help the seriously ill and initiated a new focus on scientific research, prevention and wellness.